Shin Ushijima’s comment was published in the following articles on July 24, 2024.

1. An article titled “Report on Kobayashi Pharmaceutical: Company Knew and Neglected Contamination with Blue Mold, Declaring ‘No Side Effect’ to Doctors’ Inquiries” in the Nishinippon Shimbun morning edition.

2. An article titled “Knowingly Neglected the Contamination with Blue Mold, Reported by the Inspection Committee of Kobayashi Pharmaceutical’s Beni-Koji Issue” in the To-o Nippo Press.

3. An article titled “The Spread of Damage Could Have Been Suppressed – Kobayashi Pharmaceutical Knew but Neglected Kidney Disorder” of the Ehime Shimbun.